Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001654954-16-004708
Filing Date
2016-12-09
Accepted
2016-12-09 13:05:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A defrancesco13da_dec72016.htm SC 13D/A 39660
2 TRANSACTIONS IN SHARES ex1-1.htm EX-1.1 120434
  Complete submission text file 0001654954-16-004708.txt   161718
Mailing Address 1775 38TH STREET BOULDER CO 80301
Business Address 1775 38TH STREET BOULDER CO 80301 303-545-5550
Bioptix, Inc. (Subject) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79102 | Film No.: 162043512
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 365 BAY STREET SUITE 840 TORONTO A6 M5H 2V1
Business Address
DeFrancesco Catherine Johanna (Filed by) CIK: 0001684226 (see all company filings)

Type: SC 13D/A